Discount Cards: A Rebuttal
"The real problem to be solved is “Why do patients struggle to buy their prescriptions?” writes Frisch.
Florida Declares Hepatitis A Public Health Emergency
2019 cases greater than five-year trend.
Chains Closing Stores, Opening Fewer
More jobs in jeopardy as chains struggle to save expenses.
FDA Approves Turalio (Pexidartinib) for TGCT
Kinase inhibitor oral capsules.
Improving Business Performance Through Data Driven Solutions
Caring for patients requires a successful business.
New Guidelines Stress Pharmacist Well-Being
50 new recommendations signed by organizations, schools, and regulators.
HHS, FDA Unveil Drug Importation Plan
Update: ASHP statement released.
The Need for Trauma Team Pharmacists
Survey indicates need for greater pharmacist presence.
Birth Weight, Due Date, and COPD
Natal conditions may influence susceptibility.
Opinion: Staying Afloat
PBMs are making it nearly impossible to navigate the waters of healthcare, writes Kreckle.
ASHP Releases New Guidelines for Perioperative Pharmacists
How to handle controlled substances and medication safely.
Why Advocacy and Social Media Outreach Works
New platforms can increase exposure and traffic in your stores.
Telling Pharmacists’ Stories in a Digital Age
Good Neighbor Pharmacy's transition from broadcast to digital marketing.
New Warnings for Tofacitinib Issued by FDA
Black box warns of increased risk of blood clots and death.
Supporting the Value of Independent Pharmacy and Pharmaceutical Care
Independent pharmacies differentiate with service and high-touch care.
Pharmacists at the FDA: Drug Information Specialists
Agents of regulatory guidance, drug problem reports, and whistleblowers.
FDA Issues Warning to CBD Product Suppliers
Companies have been promoting unsubstantiated health and treatment claims.
CPF and CPESN USA: Flip the Pharmacy
New program to fund community pharmacy reinvention efforts.
FDA Approves Hadlima (Adalimumab-bwwd) Biosimilar
TNF blocker biosimilar to Humira (adalimumab, Abbvie).
Opioid Prescriptions Are Still Prolific, But Deaths Fall
76 billion opioid pain pills distributed from 2012-2016.
FDA Approves Ruxience, a Rituxan Biosimilar
CD20-directed antibody indicated for several cancers and other conditions.
Criminal Opioid Charges Piling Up Against Pharmacists, Distributors
Prosecutors are bringing accountability to the opioid epidemic.
Getting to Know AmerisourceBergen’s Rich Tremonte
Q&A from ThoughtSpot 2019.
First Generic Lyrica Capsules Approved by FDA
Distributed by Invagen, a subsidiary of Cipla Ltd.
Compounding Industry on the Newest MOU Draft
FDA plans to finalize the draft in 2019.
FDA Approves Otezla (Apremilast) to Treat Oral Ulcers
Fourth indication for the drug since 2014.
Researchers Exploring Oral Flu Vaccine and Treatment Options
Biotech companies join forces to develop oral flu vaccines.
Survey Finds 45% Of Americans Have Some Doubt About Vaccine Safety
Lack of trust in vaccines abetted by online articles and past wrongdoing by the drug industry.
Opinion: Your Approach to Hiring is All Wrong
"Neither your gut nor peer advice will get you the caliber people you need", writes Nathan
Altaire Recalls Ophthalmic Products
Update: Recall expanded to Natural Ophthalmics and TRP Company, Inc.
